Therapeutic Effects of Cajuput Oil (Melaleuca Cajuputi) in Respiratory Health
A Systematic Review of Preclinical and Clinical Studies
DOI:
https://doi.org/10.55606/ijhs.v6i2.7678Keywords:
Clinical Studies, Melaleuca Cajuputi, Preclinical, Respiratory Health, TherapeuticAbstract
Respiratory tract diseases present significant challenges to global public health, requiring the development of multi-targeted, therapeutic interventions. Cajuput oil (Melaleuca cajuputi or Melaleuca leucadendra) and its primary monoterpene constituent, 1,8-cineole (eucalyptol), have demonstrated a broad spectrum of anti-inflammatory, antioxidant, spasmolytic, and antimicrobial properties. This systematic review synthesizes preclinical and clinical evidence to evaluate the therapeutic efficacy, underlying molecular mechanisms, clinical safety, and formulation advancements of cajuput oil and 1,8-cineole in managing upper and lower respiratory tract diseases. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a systematic literature search was executed across PubMed, EuropePMC, and OpenAlex databases up to early 2026. Primary studies investigating the therapeutic effects of cajuput oil or 1,8-cineole in preclinical (in vitro and in vivo) and clinical respiratory disease models were selected. Six independent reviewers conducted the study screening, selection, data extraction, and risk of bias assessment. Result: Thirteen original studies met the rigorous eligibility criteria. In vivo animal models of pulmonary emphysema, pulmonary fibrosis, and allergic asthma showed that 1,8-cineole significantly attenuates tissue destruction, inflammatory cell infiltration, and fibrotic deposition. These cellular responses were mediated by the upregulation of Nrf2-driven antioxidant cascades and the suppression of NF-κB, p38 MAPK, and STAT6 inflammatory signaling pathways. Spasmolytic activities in human bronchial tissues were achieved via reversible H₁-receptor blockade and H₂-receptor/α-adrenoceptor activation. Furthermore, 1,8-cineole exhibited strong antimicrobial and antibiofilm properties against multidrug-resistant Klebsiella pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa. In clinical trials and observational studies, oral administration of 1,8-cineole (including a novel amoxicillin-clavulanate-cineole formulation) significantly improved symptom severity and accelerated recovery in acute bronchitis, rhinosinusitis, and lower respiratory tract infections with excellent tolerability.
Downloads
References
Alves-Silva, J. M., Zuzarte, M., Marques, C., Rodrigues, T., Barbeitos, J., Caetano, R., Baptista, R., Salgueiro, L., & Girão, H. (2025). 1,8-Cineole reduces pulmonary vascular remodelling in pulmonary arterial hypertension by restoring intercellular communication and inhibiting angiogenesis. Phytomedicine, 137. https://doi.org/10.1016/j.phymed.2024.156334
André-Michael Beer, Plamen Sagorchev, & Julian Lukanov. (2019). Effects of 1,8-cineole (eucalyptol) on the activity of human bronchial tissue. Open Journal of Pulmonology and Respiratory Medicine, 12–22. https://doi.org/10.36811/ojprm.2019.110004
Barbarossa, A., Argentieri, M. P., Diella, M. V., Spinozzi, E., Maggi, F., Carrieri, A., Corbo, F., Rosato, A., & Carocci, A. (2025). Exploring the Antibacterial, Anti-Inflammatory, and Antioxidant Properties of the Natural Food Supplement “Protegol” as a Supportive Strategy in Respiratory Tract Infections. Antibiotics, 14(12). https://doi.org/10.3390/antibiotics14121260
Benjelloun, M. C., El Achhab, Y., & Nejjari, C. (2025). Efficacy and safety of a new drug formulation, amoxicillin-clavulanate-cineole, for adult lower respiratory tract infections: a nationwide observational study in Morocco. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1549014
Burns, R. B., Anandaiah, A., Rice, M. B., & Smetana, G. W. (2020). Should you recommend inhaled corticosteroids for this patient with chronic obstructive pulmonary disease?: Grand rounds discussion from beth Israel deaconess medical center. In Annals of Internal Medicine (Vol. 172, Number 11, pp. 735–742). American College of Physicians. https://doi.org/10.7326/M20-1058
Cai, Z. M., Peng, J. Q., Chen, Y., Tao, L., Zhang, Y. Y., Fu, L. Y., Long, Q. De, & Shen, X. C. (2021). 1,8-Cineole: a review of source, biological activities, and application. In Journal of Asian Natural Products Research (Vol. 23, Number 10, pp. 938–954). Taylor and Francis Ltd. https://doi.org/10.1080/10286020.2020.1839432
Cai, Z., Wang, Q., Xu, J., Zhou, J., Jiang, Z., Pan, D., Zhang, Y., Tao, L., Peng, J., Chen, Y., & Shen, X. (2022). Enhanced protective activity of 1,8-cineole on emphysema using hyaluronic acid-coated liposomes via quantitative pulmonary administration in mice. Journal of Drug Delivery Science and Technology, 72. https://doi.org/10.1016/j.jddst.2022.103402
Cao, Q., Liu, L., Ma, X., Zhong, C., Tang, M., Liu, M., Qu, L. B., Wei, B., & Xu, X. (2025). 1, 8-Cineole Ameliorated Staphylococcus aureus-Induced Pneumonia through Modulation of TRP-KYN and Arginine-NO Reprogramming. Journal of Agricultural and Food Chemistry, 73(19), 11670–11683. https://doi.org/10.1021/acs.jafc.4c10860
Dang, K., Zhang, J., Yu, K., Liu, X., Zhu, Y., Yang, X., Liu, X., & Zhang, C. (2025). Natural terpenoids with therapeutic potential against pulmonary arterial hypertension. In Frontiers in Pharmacology (Vol. 16). Frontiers Media SA. https://doi.org/10.3389/fphar.2025.1713745
Han, L., Sun, Y., Wang, Y., Wang, Q., Zhang, X., He, H., & Wang, J. (2026). Natural therapeutics and traditional formulas targeting macrophage polarization in the fibrotic niche of idiopathic pulmonary fibrosis. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1860332
Juergens, U. R. (2014). Anti-inflammatory properties of the monoterpene 18-cineole: Current evidence for co-medication in inflammatory airway diseases. In Drug Research (Vol. 64, Number 12, pp. 638–646). Georg Thieme Verlag. https://doi.org/10.1055/s-0034-1372609
Kardos, P., Khaletskaya, O., & Kropova, O. (2021). Efficacy and safety of Cineole (Soledum®) in the treatment of patients with acute bronchitis: results of an open-label randomized clinical phase III study. Clinical Phytoscience, 7(1). https://doi.org/10.1186/s40816-021-00319-8
Kennedy-Feitosa, E., Cattani-Cavalieri, I., Barroso, M. V., Romana-Souza, B., Brito-Gitirana, L., & Valenca, S. S. (2019). Eucalyptol promotes lung repair in mice following cigarette smoke-induced emphysema. Phytomedicine, 55, 70–79. https://doi.org/10.1016/j.phymed.2018.08.012
Li, L., Gao, X., Li, M., Liu, Y., Ma, J., Wang, X., Yu, Z., Cheng, W., Zhang, W., Sun, H., Song, X., & Wang, Z. (2024). Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies. In Frontiers in Cellular and Infection Microbiology (Vol. 14). Frontiers Media SA. https://doi.org/10.3389/fcimb.2024.1324895
Li, L. Y., Zhang, C. T., Zhu, F. Y., Zheng, G., Liu, Y. F., Liu, K., Zhang, C. H., & Zhang, H. (2022). Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview. In Frontiers in Pharmacology (Vol. 13). Frontiers Media S.A. https://doi.org/10.3389/fphar.2022.821941
Liu, X., Xu, L., Zhong, X., & Zhang, J. (2026). Baricitinib alleviates interstitial lung disease in CIA mice by inhibiting macrophage polarization and increase exosomal miR-126a-3p with anti-fibrotic activity in vitro. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1747540
Markowski, J., & Junka, A. (2025). Multifaceted Action of 1,8-Cineole in Antibacterial and Anti-inflammatory Treatment of Respiratory Tract Diseases. Otolaryngologia Polska, 79(1), 1–5. https://doi.org/10.5604/01.3001.0054.9607
Peng, J., Wang, Q., Sun, R., Zhang, K., Chen, Y., & Gong, Z. (2024). Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis. Journal of Controlled Release, 371, 1–15. https://doi.org/10.1016/j.jconrel.2024.05.026.
Rui, Y., Han, X., Jiang, A., Hu, J., Li, M., Liu, B., Qian, F., & Huang, L. (2022). Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. European Journal of Pharmacology, 931. https://doi.org/10.1016/j.ejphar.2022.175184
Schürmann, M., Oppel, F., Gottschalk, M., Büker, B., Jantos, C. A., Knabbe, C., Hütten, A., Kaltschmidt, B., Kaltschmidt, C., & Sudhoff, H. (2019). The therapeutic effect of 1,8-cineol on pathogenic bacteria species present in chronic rhinosinusitis. Frontiers in Microbiology, 10(OCT). https://doi.org/10.3389/fmicb.2019.02325
Sudiansyah, M. I., Yusro, F., & Mariani, Y. (2023). Aktivitas Antibakteri Ekstrak Kulit Batang Gelam (Melaleuca leucadendra Linn.) terhadap Salmonella enterica serovar Typhimurium. Jurnal Serambi Engineering, 8(3), 6161–6167.
Vazquez, N. M., Moreno, S., & Galván, E. M. (2022). Exposure of multidrug-resistant Klebsiella pneumoniae biofilms to 1,8-cineole leads to bacterial cell death and biomass disruption. Biofilm, 4. https://doi.org/10.1016/j.bioflm.2022.100085
Wang, Y., Zhu, J., Zhang, X., Tong, F., & Xu, Q. (2026). Anti-inflammatory effects of 1, 8-cineol via NF-κB/COX-2 pathway in BEAS-2B cells and alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1714915
Werkhäuser, N., Pieper-Fürst, U., Sahin, H., Claas, A., & Mösges, R. (2023). Rhinosinusitis Treatment with Cineole: Patient-Reported Quality of Life Improvements from a Non-Interventional, Pharmacy-Based Survey. Medicines, 10(6), 37. https://doi.org/10.3390/medicines10060037.
Zaky, N., Wibowo, T., Retnowati, W., Hasanatuludhhiyah, N., Dwi, A., & Widodo, W. (2023). Antibacterial Activity of Cajeput Oil (Melaleuca leucadendra) from UMKM Lamongan against Pseudomonas aeruginosa. International Journal of Research Publication, 137(1), 102–109. https://doi.org/10.47119/10.47119/IJRP10013711120235672
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal Of Health Science

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.





